Large PBMs Balk at Push to Reduce Drug Prices

In a move that exemplifies the potential conflict of interest that some large pharmacy benefit managers have, the nation’s largest PBM earlier this year said it would demand that rebates remain unchanged when drug makers roll out new price cuts. Drug makers earlier in the year said they would start reducing prices as well as [...]

By | 2019-11-19T12:16:12-08:00 November 19th, 2019|Uncategorized|0 Comments

Pharmacy Benefit Managers: A Brake on Rising Prescription Costs or a Cause of Them?

In 2015, spending on prescription drugs grew 9%, faster than any other category of health care spending, according to the U.S. Centers for Medicare and Medicaid Services. The report cited increased use of new medicines, price increases for existing ones, and more spending on generic drugs as the reasons for this growth. Increasingly, though, observers [...]

By | 2019-08-08T09:55:20-07:00 August 8th, 2019|Uncategorized|0 Comments
Top